STAP Papers Retracted

Nature issues retractions of the stimulus-triggered acquisition of pluripotency papers and pens an editorial on the controversy surrounding their publication.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

HARUKO OBOKATAAfter months of failed replication attempts, institutional investigations, findings of research misconduct, and several calls for retractions, RIKEN’s Haruko Obokata and her colleagues today (July 2) pulled both of their stimulus-triggered acquisition of pluripotency (STAP) studies. Also retracted was Austin Smith’s News and Views article, which accompanied the two STAP papers when they were published in Nature in January. Smith, a stem-cell researcher from the University of Cambridge, wrote in a Nature notice that his comments were “based on the accuracy and reproducibility of [Obokata and her colleagues’] data.”

In an editorial published today, the journal’s editors said they had verified that STAP was independently replicated in the coauthors’ labs before publishing the studies, and that reviewers of the work “could not have detected the problems that fatally undermined the papers.” Rather, the editors said, Nature was misled by the studies’ authors (specifically, in their contributions statements). “The referees’ rigorous reports quite rightly took on trust what was presented in the papers,” the editors wrote.

“In short: although editors and referees could not have detected the fatal faults in this work, the episode has further highlighted flaws in Nature’s procedures and in the procedures of institutions that publish with us,” the journal’s staff concluded.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Tracy Vence

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo